← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2010Last known activity
Dec 31, 2022
Acquired by Panbela Therapeutics on Feb 22, 2022
Timeline
2000s
- Jun 1, 2008
Cancer Prevention Pharmaceuticals, Inc.— Founded
2020s
- Feb 22, 2022
Panbela Therapeutics— Acquired By
Drugs by trial phase (4 distinct, 8 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT05594563CollaboratorPhase 2Dec 31, 2022
- NCT02794428CollaboratorPhase 2Sep 19, 2016
- NCT01636128Lead sponsorPhase 2Mar 1, 2014
- NCT01483144Lead sponsorPhase 3Oct 1, 2013
- NCT01349881CollaboratorPhase 3Mar 1, 2013
- NCT01586260CollaboratorPhase 2Jun 1, 2012
- NCT01245816Study directorPhase 3Mar 1, 2011
- NCT01245816Lead sponsorPhase 3Mar 1, 2011
- NCT01059071CollaboratorPhase 1Feb 1, 2010
Details
- Founded
- Tucson, Arizona, US Jun 1, 2008
- Last known activity
- Dec 31, 2022